Abstract 16655: Liver Fibrosis Severity is Associated with Congestive Heart Failure in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease
Background - Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a systemic cardiometabolic disorder. Although cardiovascular disease is the leading cause of mortality in MASLD, the relationship between liver fibrosis severity and congestive heart failure (CHF) at the popul...